ReproCELL Inc. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
132,869.00
456,920.00
1,979,439.00
937,078.00
2,281,556.00
Depreciation, Depletion & Amortization
10,333.00
135,505.00
325,814.00
255,148.00
253,484.00
Other Funds
20,441.00
61,800.00
8,755.00
-
-
Funds from Operations
44,169.00
493,809.00
628,404.00
631,356.00
691,710.00
Changes in Working Capital
5,127.00
132,989.00
14,028.00
143,669.00
54,990.00
Net Operating Cash Flow
39,042.00
626,798.00
614,376.00
775,025.00
636,720.00
Capital Expenditures
4,107.00
35,029.00
49,417.00
65,546.00
43,355.00
Purchase/Sale of Investments
50,000.00
1,025,683.00
59,170.00
751,041.00
206,830.00
Net Investing Cash Flow
54,092.00
2,683,854.00
568,828.00
685,715.00
228,023.00
Issuance/Reduction of Debt, Net
-
269,013.00
2,225.00
4,832.00
2,951.00
Net Financing Cash Flow
5,016,974.00
2,016,219.00
1,700,107.00
1,127,662.00
1,028,650.00
Net Change in Cash
4,926,860.00
1,250,993.00
490,651.00
1,004,104.00
160,013.00
Free Cash Flow
43,149.00
658,618.00
643,505.00
840,571.00
680,075.00
Net Assets from Acquisitions
-
1,623,142.00
441,363.00
-
-
Other Sources
15.00
-
-
221.00
22,162.00
Change in Capital Stock
5,037,415.00
2,347,032.00
1,693,577.00
1,132,494.00
1,031,602.00
Exchange Rate Effect
3,020.00
43,440.00
26,252.00
34,248.00
3,894.00
Other Uses
-
-
18,878.00
-
-

About ReproCELL

View Profile
Address
KDX Shin-Yokohama 381 Building, 9/F
Yokohama Kanagawa 222
Japan
Employees -
Website http://www.reprocell.com
Updated 09/14/2018
ReproCELL Inc. engages in the development of diverse products with an underlying theme that focuses on stem cell technology. It operates through the following business divisions: Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells and Clinical Testing. The Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells division handles the manufacture and sale of research reagents, and the production and evaluation of cells.